Fidelity Investments’s Acrivon Therapeutics ACRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.7K | Buy |
9,850
+7,185
| +270% | +$8.55K | ﹤0.01% | 4485 |
|
|
2025
Q1 | $5.41K | Sell |
2,665
-268
| -9% | -$544 | ﹤0.01% | 4676 |
|
|
2024
Q4 | $17.7K | Buy |
2,933
+352
| +14% | +$2.12K | ﹤0.01% | 4228 |
|
|
2024
Q3 | $18.1K | Buy |
2,581
+933
| +57% | +$6.53K | ﹤0.01% | 4215 |
|
|
2024
Q2 | $9.56K | Buy |
1,648
+621
| +60% | +$3.6K | ﹤0.01% | 4340 |
|
|
2024
Q1 | $7.34K | Buy |
1,027
+221
| +27% | +$1.58K | ﹤0.01% | 4378 |
|
|
2023
Q4 | $3.97K | Buy |
806
+518
| +180% | +$2.55K | ﹤0.01% | 4511 |
|
|
2023
Q3 | $2.75K | Sell |
288
-134
| -32% | -$1.28K | ﹤0.01% | 4464 |
|
|
2023
Q2 | $5.47K | Buy |
422
+300
| +246% | +$3.89K | ﹤0.01% | 4340 |
|
|
2023
Q1 | $1.55K | Buy |
+122
| New | +$1.55K | ﹤0.01% | 4682 |
|